Human Immunology Symposium 2017

Despite the progress that has been made in understanding the immune response to viral infections, we still do not have effective vaccines against chronic viruses like human immunodeficiency virus (HIV) and hepatitis C virus (HCV).

Earlier efforts have focused on developing T cell based vaccines but results from clinical trials for an HIV T-cell based vaccine were disappointing. This shifted the attention to antibodies or B cell based vaccines. On the other hand, T cell based vaccines were shown to be effective against HCV infection in a chimpanzee model and phase 2 clinical trials are underway. Recent data from different models of viral infections suggest that there is extensive cross-regulation between innate immunity and B cells (ex. via type I IFNs) and between T cells and B cells (via follicular helper T cells, regulatory T and B cells).

It has also become apparent that results in mice and animal models are not reflective of “real-life” infections and vaccinations in the human population. Altogether, the current state of knowledge requires a step back to examine recent findings about the role of B versus T cells in the context of real-life human infections and vaccination.

The goal of this one day symposium is to bring together experts from Canada and the world to discuss these issues focusing on human viral infections like Flu, #Ebola, #HCV, #HIV and #hepatitis B virus (#HBV).

The symposium will be held September 22nd in Montreal at the Centre de recherche du CHUM Auditorium.

More info on fourwaves: http://fourwav.es/HIS-Montreal

Like what you read? Give Matthieu Chartier a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.